Lymphoma & related disorders

Mature B cell neoplasms

Large B cell lymphomas-special subtypes

Fluid overload associated LBCL



Last author update: 19 October 2023
Last staff update: 19 October 2023

Copyright: 2022-2024, PathologyOutlines.com, Inc.

PubMed Search: Fluid overload lymphoma

Patrick Bladek, M.D.
Carlos A. Murga-Zamalloa, M.D.
Page views in 2023: 423
Page views in 2024 to date: 100
Cite this page: Bladek P, Murga-Zamalloa C. Fluid overload associated LBCL. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lymphomafluidoverloadlbcl.html. Accessed November 28th, 2024.
Definition / general
  • Body cavity large B cell lymphoma with no associated solid lymphoma involvement in immunocompetent individuals
  • Negative for HHV8 infection and does not occur in the setting of chronic inflammatory / infectious related effusions
Essential features
  • B cell lymphoma composed of large malignant cells present in body cavity effusions without any solid tissue lymphoma involvement
  • Predominantly diagnosed in elderly and immunocompetent individuals with comorbidities that put them at risk for developing body cavity effusions (e.g., congestive heart failure, cirrhosis)
  • Not associated with HHV8 infection
  • EBV infection can be detected only in a minority of cases
  • Tumor cells are frequently positive for B cell markers (CD20, PAX5) and most are of nongerminal center type per the Hans algorithm
  • References: Mod Pathol 2022;35:1411, J Blood Med 2021;12:833, J Am Soc Cytopathol 2015;4:37, Blood Adv 2020;4:4442, Histopathology 2018;72:930
Terminology
  • Primary effusion lymphoma (PEL)-like lymphoma
  • HHV8 negative effusion based large B cell lymphoma
  • HHV8 negative malignant effusion lymphoma
  • PEL-like lymphoma
  • HHV8 unrelated PEL-like lymphoma
  • Type II PEL
ICD coding
  • ICD-10: C83.8 - other nonfollicular lymphoma
  • ICD-11: 2A81.9 - primary effusion lymphoma
Epidemiology
  • Represents < 1% of all diagnosed lymphomas
  • Predominantly elderly patients (median age: 79)
  • M:F = 1.26:1
  • HIV positive (2% of individuals)
  • Risk of fluid overload (e.g., congestive heart failure, cirrhosis) in 50 - 79% of cases
  • References: Leuk Lymphoma 2017;58:80, Mod Pathol 2022;35:1411
Sites
  • Body cavities, predominantly the pleural cavity
  • May also be present in pericardial and peritoneal fluids
  • Solid lymphoma involvement is absent
  • Reference: Mod Pathol 2022;35:1411
Pathophysiology
  • Most of the reported cases derive from postgerminal center B cell lymphocytes (Blood 2019;133:377)
Etiology
Clinical features
Diagnosis
  • Nongynecological cytology analysis of effusion fluid
  • Flow cytometry analysis of effusion fluid
Laboratory
  • Findings depend on the site of fluid effusion and are otherwise nonspecific
  • Lactate dehydrogenase (LDH) is typically elevated
Prognostic factors
  • Overall survival was 11 months for non-Japanese residents and the median overall survival was 63.6 months for Japanese residents
  • Presence of MYC rearrangements is associated with the worst survival
  • Age of ≥ 79 is an independent unfavorable predictor
  • References: Mod Pathol 2022;35:1411, Haematologica 2002;87:339
Case reports
Treatment
  • No standardized therapeutic approach is available due to the limited number of cases reported
  • First line management usually includes rituximab combined with systemic chemotherapy
  • Therapeutic drainage of effusions as the sole therapeutic intervention is performed in patients unsuitable for systemic chemotherapy
  • Reference: Mod Pathol 2022;35:1411
Cytology description
Cytology images

Contributed by Carlos A. Murga-Zamalloa, M.D.
Cell block preparation

Cell block preparation

Cell block preparation (CD20)

Cell block preparation (CD20)

Cell block preparation (MUM1)

Cell block preparation (MUM1)

Cell block preparation (HHV8)

Cell block preparation (HHV8)

Cytospin preparation (Wright-Giemsa) Cytospin preparation (Wright-Giemsa)

Cytospin preparation (Wright-Giemsa)

Positive stains
Negative stains
Molecular / cytogenetics description
  • BCL2 rearrangement (8 - 29% of cases)
  • BCL6 rearrangement (11 - 21% of cases)
  • MYC rearrangement (11 - 22% of cases)
  • Recurrent mutations in MYD88 (including L265P) are identified in some cases (Blood 2019;133:377)
Sample pathology report
  • Pleural fluid, thoracocentesis:
    • Involved by HHV8 negative large B cell lymphoma (see comment)
    • Comment: In the right clinical context and with the absence of involvement by lymphoma in solid tissues, the diagnosis is consistent with fluid overload associated LBCL.
Differential diagnosis
  • Primary effusion lymphoma:
    • HHV8 positive
    • Detected in immunodeficient patients
    • Usually negative for pan-B cell markers (CD20, PAX5)
    • Tumor cells are mostly positive for CD30 and CD138
  • Pyothorax associated lymphoma:
    • Occurs in the setting of chronic inflammation and is EBV driven
    • Patients are usually young with a longstanding history of pyothorax or pleuritis secondary to infectious etiologies (e.g., tuberculosis)
    • Associated with solid lesions in the pleura or lung
  • B cell lymphomas with associated pleural effusions:
Board review style question #1

Which of the following is true regarding fluid overload associated LBCL?

  1. Association with tuberculosis related chronic pleural effusions is commonly observed
  2. Clinical course is usually indolent
  3. Diagnosis is usually established from lymph node biopsies
  4. Patients are usually young individuals
  5. Tumor cells are frequently positive for pan-B cell markers
Board review style answer #1
E. Tumor cells are frequently positive for pan-B cell markers, including CD20, PAX5 and CD79a. Answer A is incorrect because in contrast to pyothorax associated lymphoma, fluid overload associated LBCL is not associated with infectious / chronic pleural effusions, such as those associated with tuberculosis. Answer C is incorrect because per definition, no solid lymphoma involvement is detected. Answer B is incorrect because although initial reports suggested indolent clinical behaviors, larger series demonstrate poor clinical outcomes. Answer D is incorrect because this entity is predominantly diagnosed in elderly individuals and the median age of diagnosis is 79 years.

Comment Here

Reference: Fluid overload associated LBCL
Board review style question #2
Which of the following is true regarding fluid overload associated LBCL?

  1. Cases are only delimited to the pleural cavity
  2. Cell of origin is predominantly germinal center type (by the Hans algorithm)
  3. Expression of CD30 is observed in virtually all the cases
  4. Patients are usually elderly immunocompetent individuals
  5. Presence of MYC rearrangements excludes the diagnosis
Board review style answer #2
D. Patients are usually elderly immunocompetent individuals. Most cases are detected in immunocompetent and elderly individuals. Answer A is incorrect because the tumor cells can involve other body cavities different from the pleural cavity, including the pericardial and peritoneal cavities. Answer C is incorrect because only 10 - 27% of the cases feature variable CD30 positive staining. Answer B is incorrect because the majority of the cases are nongerminal center types per the Hans algorithm. Answer E is incorrect because the presence of MYC rearrangements is associated with decreased survival and poor prognosis.

Comment Here

Reference: Fluid overload associated LBCL
Back to top
Image 01 Image 02